The University of South Florida (USF Health) found extremely low levels of delta-9-tetrahydrocannabinol or most famously THC, may slow or halt progression of Alzheimer’s disease.
These low doses reduce the production of amyloid beta, found in a soluble form in most aging brains and prevent abnormal accumulation of this protein. Additionally, it also selectively enhanced mitochondrial function needed to help supply energy, transmit signals and maintain a healthy brain.
“Decreased levels of amyloid beta means less aggregation, which may protect against the progression of Alzheimer’s disease. Since THC is a natural and relatively safe amyloid inhibitor, THC or its analogs may help us develop an effective treatment in the future.”
It was also noted that at the low doses studied, the therapeutic benefits of THC appear to prevail over the associated risks of THC toxicity and memory impairment. The body’s own cannabinoid receptors interact with naturally-occuring cannabinoids and these molecules function similarly to the THC from the cannabis plant.
For more information and links to the study visit: http://tinyurl.com/mlv7oyw